Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Italy's $10 Billion Pharma Family Makes A U.S. Power Move
or more than 100 years, the billionaire Angelini family had been content to run a largely European business empire from their headquarters in Rome: pharmaceuticals like the Italian equivalent of Tylenol and the antidepressant trazodone, as well as…
Vistin Pharma ASA: Second quarter and YTD 2026 financial results
Vistin Pharma ASA (VISTN) today announces its financial results for the second quarter and first half of 2026. Revenue in the second quarter amounted to MNOK 100, compared to MNOK 118 in Q2 2025. Sales volume increased by 8%, offset by a…
Hang Seng climbs nearly 1 percent as pharma and gold stocks surge
Hong Kong stocks closed higher on Thursday, broadly boosted by a surge in pharmaceutical and gold shares, while tech heavyweights posted mixed results. SCROLL TO CONTINUE WITH CONTENT The benchmark Hang Seng Index rose 231 points, or 0.91 percent…
HSI rose 291 points by midday as pharma and commodity shares rally, Kuaishou fell 9.74pc
Hong Kong stocks sustained their upward momentum at noon on Thursday as biopharmaceutical and commodity shares gained further. SCROLL TO CONTINUE WITH CONTENT The benchmark Hang Seng Index rose 291 points, or 1.14 percent, to 25,786 points…
Xeris Biopharma: A Commercial Stage Pharma That May Be A Slow-Burn Buy Opportunity (XERS)
Xeris Biopharma Holdings, Inc. achieved record 2024 revenues of $203M, up 24%, with robust growth across all three commercial products. 2025 revenue guidance of $255M–$275M implies 30% growth for XERS at midpoint, supporting a forward P/S…
Ascendis Pharma (ASND) Q2 2026 Earnings Call Transcript
Thursday, Aug. 13, 2026 at 8 a.m. ET Vice President of Investor Relations - Chad Fugure President and Chief Executive Officer - Jan Mikkelsen Chief Financial Officer - Scott Smith Chief Business Officer - Sherrie Glass Executive Vice President and…
IHE vs. XBI: Pharma Stability or Biotech Growth -- Which Healthcare ETF Is the Better Buy?
Comparing the iShares U.S. Pharmaceuticals ETF (IHE +2.71%) to the State Street SPDR S&P Biotech ETF (XBI +5.90%) illustrates a familiar healthcare trade-off: the relative stability of massive pharmaceutical conglomerates versus the high-volatility…
Pulse Pharma gets DCGI nod for nano-carrier entrapped Vitamin D3 oral dispersion
Pulse Pharmaceuticals has received approval for its nano-carrier entrapped Vitamin D3 oral dispersion from the Drugs Controller General of India (DCGI). The approval transforms advanced nano pharmaceutical research into a regulated, patient-ready…
Mankind Pharma inks in-licensing pact with China's Chongqing Chenan Biopharmaceutical on two insulin analogues
Mankind Pharma has inked an exclusive in-licensing and marketing agreement with China 's Chongqing Chenan Biopharmaceutical Co Ltd, to commercialise two insulin analogues - Insulin Degludec and Insulin Degludec + Aspart Combination, in India. The…
Ascendis Pharma A/S (NASDAQ:ASND) Upgraded to Strong-Buy at BMO Capital Markets
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) was upgraded by BMO Capital Markets to a 'strong-buy' rating in a note issued to investors on Tuesday, Marketbeat.com reports. Can BioMarin Stock Live Up to Wall Street's High Expectations? Other…
Ascentage Pharma Group International H1 Earnings Call Highlights
Ascentage Pharma Group International NASDAQ: AAPG reported first-half 2026 revenue growth as it continued investing in global registrational studies for its hematology-oncology pipeline and began building commercial capabilities outside China.
30,000 Shares in Royalty Pharma PLC $RPRX Purchased by Monetta Financial Services Inc.
Monetta Financial Services Inc. acquired a new position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired…
Forbes Daily: Moderna Stock Surges On Landmark Cancer Vaccine Trial
Moderna had its best trading day ever as the company reported positive results from a landmark cancer vaccine trial. The biotech giant's stock skyrocketed 177% Wednesday after Moderna and Merck reported that their vaccine helped reduce the…
Walmart reports mixed results as gas prices drag on US sales growth
Walmart reported mixed results Thursday, topping analyst estimates but experiencing slower US sales growth as consumers contended with lofty gasoline prices due to the US-Iran war. The giant US retailer steered much of the benefit from US tariff…
The Algorithm Inside Moderna's Cancer Vaccine, and the Pharma AI Race It Reframes
On August 19, 2026, Moderna and Merck announced that their personalized mRNA cancer vaccine met the main goal of a large late-stage trial in melanoma. The INTerpath-001 study enrolled 1,137 patients whose cutaneous melanoma had been surgically…
Receive a Daily briefing on Pharma Industry News
Get Started